Australasian Collaborative Trial of Vaginal Progesterone Therapy

Not Applicable

Completed

• Conditions: eonatal respiratory distress syndrome; Neonatal Diseases; Respiratory distress syndrome

• Registration Number: ISRCTN20269066
• Lead Sponsor: The University of Adelaide (Australia)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09-19
• Last Update Posted: 15 January 2018

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 984

Inclusion Criteria

Pregnant women with a history of prior spontaneous preterm birth at less than 34 weeks gestation.

Exclusion Criteria

Women with preterm prelabour ruptured membranes, active labour (defined as the presence of uterine activity and cervical dilatation greater than 3 cm), known fetal anomaly, or any contraindication to progesterone therapy or to continuation of the pregnancy (e.g. chorioamnionitis requiring delivery).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eonatal lung disease

Secondary Outcome Measures

Name	Time	Method
1. Adverse outcomes for the woman<br>2. Maternal emotional wellbeing<br>3. Adverse outcomes for the infant<br>4. Costs of health care